Barbara Ehrlich, PhD

Dr. Barbara Ehrlich is the scientific founder of Osmol, she currently serves as Professor of Pharmacology at Yale University and is Osmol’s Chief Scientific Advisor. Her work is focused on understanding intracellular calcium signaling and how abnormalities in calcium regulation can explain disease processes with a current focus on the molecular basis for chemotherapy induced peripheral neuropathy and optimizing strategies to prevent this devastating side effect of cancer treatment. Dr. Ehrlich received her ScB in Applied Mathematics and Biology from Brown University and her PhD in Physiology from UCLA.